prostate cancer Cancer
overexpressed cancer cells
TRPV1 biology
understanding of cancer biology
TRPV1-targeted ligand-drug conjugates
diseased prostate cells
animal optical imaging of TRPV1
tackle PC
unprecedented approach
targeted therapies
novel signalling pathways
disruption of calcium signalling
overexpressed transient receptor potential vanilloid channel V1
innovative chemotypes
original means
development of candidate therapeutic agents
leading cause of death
devlopment
chemical probes
pioneering technological advance
delivery of cytotoxic payloads
urgent need
major advances
strategy
morbidity
validation
non-skin cancers
Evidence